Measurement of d-amphetamine-induced effects on the binding of dopamine D-2/D-3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non-human primates using PET

Brain Research

Volumn 1032, Issue 1-2, 2005, Pages 77-84

  Mukherjee, Jogeshwar ^a   Christian, Bradley T ^b   Narayanan, Tanjore K ^b   Shi, Bingzhi ^b   Collins, Daphne ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

Author keywords

18F fallypride; Amphetamine; Dopamine release; Extrastriatal D 2 receptors; PET

Indexed keywords

DEXAMPHETAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; FALLYPRIDE F 18; RADIOLIGAND; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN REGION; CAUDATE NUCLEUS; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DATA ANALYSIS; DOPAMINE RELEASE; DRUG DISTRIBUTION; FRONTAL CORTEX; HYPOPHYSIS; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; TEMPORAL CORTEX; THALAMUS;

AMPHETAMINE; ANIMALS; BENZAMIDES; BRAIN; BRAIN MAPPING; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FLUORINE RADIOISOTOPES; MACACA MULATTA; MALE; POSITRON-EMISSION TOMOGRAPHY; PYRROLIDINES; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; TIME FACTORS;

EID: 12844288988     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.11.005     Document Type: Article

References (32)

1. A. Abi-Dargham Do we still believe in the dopamine hypothesis? New data bring new evidence Int. J. Neuropsychopharmacol. 7 2004 S1 S5
2. R.D. Badgaiyan, A.J. Fischman, and N.M. Alpert Striatal dopamine release during unrewarded motor task in human volunteers NeuroReport 14 2003 1421 1424
3. G. Brix, J. Zaers, L.E. Adam, M.E. Bellemann, H. Ostertag, H. Trojan, U. Haberkorn, J. Doll, F. Oberdorfer, and W.J. Lorenz Performance evaluation of a whole body PET scanner using the NEMA protocol J. Nucl. Med. 38 1997 1614 1623
4. 18F-Fallypride binding in never-medicated patients with schizophrenia Biol. Psychiatry 55 Suppl. 8 2004 252
5. Y.-H. Chou, C. Halldin, and L. Farde Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain Synapse 38 2000 138 143
6. B.T. Christian, B. Shi, T.K. Narayanan, and J. Mukherjee Quantitation of striatal and extrastriatal dopamine D-2 receptors using PET imaging of F-18 fallypride in nonhuman primates Synapse 38 2000 71 79
7. 18F-fallypride in the thalamus in monkey PET studies Abstr.-Soc. Neurosci. 27 2001 774.4
8. 18F-fallypride in monkeys using a PET multiple-injection protocol J. Cereb. Blood Flow Metab. 24 2004 309 322
9. S.J. Cragg, C.J. Hille, and S.A. Greenfield Dopamine release and uptake dynamics within nonhuman primate striatum in vitro J. Neurosci. 20 2000 8209 8217
10. M.D. Devous, M.H. Trivedi, and A.J. Rush Regional cerebral blood flow response to oral amphetamine challenge in healthy volunteers J. Nucl. Med. 42 2001 535 542
11. C.J. Endres, and R.E. Carson Assessment of dynamic neurotransmitter changes with bolus or infusion delivery of neuroreceptor ligands J. Cereb. Blood Flow Metab. 18 1998 1196 1210
12. H. Hall, G. Sedvall, O. Magnusson, J. Kopp, C. Halldin, and L. Farde Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain Neuropsychopharmacology 11 1994 245 256
13. R.M. Kessler, S. Ansari, J.R. Votaw, T. de Paulis, J.A. Clanton, D.E. Schmidt, N.S. Mason, and R.G. Manning Identification of extrastriatal dopamine D-2 receptors in post mortem human brain with 125I-epidepride Brain Res. 609 1993 237 243
14. R. Kuczenski, D. Segal, and M.L. Aizenstein Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics J. Neurosci. 11 1991 2703 2712
15. M. Laruelle Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review J. Cereb. Blood Flow Metab. 20 2000 423 451
16. J. Logan, N.D. Volkow, J.S. Fowler, G.J. Wang, S.L. Dewey, R. Macgregor, D. Schlyer, S.J. Gatley, N. Pappas, P. King, R. Hitzemann, and S. Vitkun Effects of blood-flow on C-11 raclopride binding in the brain-model simulations and kinetic-analysis of pet data J. Cereb. Blood Flow Metab. 14 1994 995 1010
17. B. Moghaddam, C.W. Berridge, P.S. Goldman-Rakic, B.S. Bunney, and R.H. Roth In vivo assessment of basal and drug-induced dopamine release in cortical and subcortical regions of the anesthetized primate J. Neurosci. 13 1993 215 222
18. J. Mukherjee, Z.Y. Yang, R. Lew, T. Brown, S. Kronmal, M. Cooper, and L.S. Seiden Evaluation of d-amphetamine effects on the binding of dopamine D-2 receptor radioligand, [F-18]fallypride in non-human primates using positron emission tomography Synapse 27 1997 1 13
19. J. Mukherjee, Z.Y. Yang, T. Brown, M. Wernick, N.J. Yasillo, X. Ouyang, C.-T. Chen, R. Mintzer, and M. Cooper Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and non-human primate brains using the high affinity radioligand, [F-18]fallypride Nucl. Med. Biol. 26 1999 519 527
20. 18F- fallypride Neuropsychopharmacology 25 2001 476 488
21. 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors Synapse 46 2002 170 188
22. A.S. Nagano, K. Ito, T. Kato, Y. Arahata, T. Kachi, K. Hatano, Y. Kawasumi, A. Nakamura, T. Yamada, Y. Abe, and T. Ishigaki Extrastriatal mean regional uptake of fluorine-18-FDOPA in the normal aged brain-an approach using MRI-aided spatial normalization Neuroimage 11 2000 760 766
23. T. Okauchi, T. Suhara, J. Maeda, K. Kawabe, S. Obayashi, and K. Suzuki Effect of endogenous dopamine on extrastriatal 11C-FLB 457 binding measured by PET Synapse 41 2001 87 95
24. J.C. Price, S. Mason, B. Lopresti, D. Holt, N.R. Simpson, W. Drevets, G.S. Smith, and C.A. Mathis PET measurement of endogenous neurotransmitter activity using high and low affinity radiotracers Neuroimage 5: 1997 B77
25. P. Riccardi, M. Sib Ansari, R. Li, D. Zald, S. Park, B. Dawant, S. Anderson, M. Doop, E. Schoenberg, and R. Kessler Amphetamine induced displacement of 18F-fallypride in striatum and extrastriatal regions NeuroImage 22 2004 T128 T129
26. 18F-fallypride in vivo binding to D2 receptors in striatal and extrastriatal regions of the primate brain: single bolus and bolus plus constant infusion studies Synapse 54 2004 46 63
27. M. Talvik, A.L. Nordstrom, H. Olsson, C. Halldin, and L. Farde Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with 11C-FLB 457 Int. J. Neuropsychopharmacol. 6 2003 361 370
28. N.P. Verhoeff Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders Psychopharmacology 147 1999 217 249
29. V.L. Villemagne, D.F. Wong, F. Yokoi, M. Stephane, K.C. Rice, D. Matecka, D.J. Clough, R.F. Dannals, and R.B. Rothman GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by 11C-raclopride continuos infusion PET scans Synapse 33 1999 268 273
30. N.D. Volkow, J.S. Fowler, G.-J. Wang, and J.M. Swanson Dopamine in drug abuse and addiction: results from imaging studies and treatment implications Mol. Psychiatry 9 2004 557 569
31. F. Yasuno, T. Suhara, Y. Okubo, Y. Sudo, M. Inoue, T. Ichimiya, A. Takano, K. Nakayama, C. Halldin, and L. Farde Low dopamine D2 receptor binding in subregions of the thalamus in schizophrenia Am. J. Psychiatr. 161 2004 1016 1022
32. H. Zaidi, and V. Sossi Correction for image degrading factors is essential for accurate quantification of brain function using PET Med. Phys. 31 2004 423 426